StreetInsider.com News Articles

Form 4 ALLURION TECHNOLOGIES, For: Jul 21 Filed by: RTW INVESTMENTS, LP

Thu, 23 Jul 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260723/26809035.html

Form 4 ALLURION TECHNOLOGIES, For: Jul 21 Filed by: RTW INVESTMENTS, LP

Thu, 23 Jul 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260723/26809035.html

Form 4 ALLURION TECHNOLOGIES, For: Jul 21 Filed by: RTW INVESTMENTS, LP

Thu, 23 Jul 2026 17:10:00 -0400

si-local-file:///var/storage/secattach/20260723/26809035.html

Allurion Technologies CEO resigns, COO to oversee operations

Thu, 23 Jul 2026 17:04:26 -0400

Allurion Technologies (OTC: ALUR) announced that Shantanu K. Gaur, M.D. resigned as Chief Executive Officer and as a member of the company's board of directors, effective July 17, 2026.

According to a company statement, Dr. Gaur's resignation was not the result of any disagreement with the company or the board on any matter relating to operations, policies, or practices.

The board has not appointed an interim or permanent Chief Executive Officer following the departure. Chief Operating Officer Ojas Buch will oversee day-to-day operations, including certain responsibilities previously held by Dr. Gaur. The company noted that Buch's title and compensation arrangements have not

Allurion Technologies CEO resigns, COO to oversee operations

Thu, 23 Jul 2026 17:04:26 -0400

Allurion Technologies (OTC: ALUR) announced that Shantanu K. Gaur, M.D. resigned as Chief Executive Officer and as a member of the company's board of directors, effective July 17, 2026.

According to a company statement, Dr. Gaur's resignation was not the result of any disagreement with the company or the board on any matter relating to operations, policies, or practices.

Allurion Technologies CEO resigns, COO to oversee operations

Thu, 23 Jul 2026 17:04:26 -0400

Allurion Technologies (OTC: ALUR) announced that Shantanu K. Gaur, M.D. resigned as Chief Executive Officer and as a member of the company's board of directors, effective July 17, 2026.

According to a company statement, Dr. Gaur's resignation was not the result of any disagreement with the company or the board on any matter relating to operations, policies, or practices.

Allurion Technologies CEO resigns, COO to oversee operations

Thu, 23 Jul 2026 17:04:26 -0400

Allurion Technologies (OTC: ALUR) announced that Shantanu K. Gaur, M.D. resigned as Chief Executive Officer and as a member of the company's board of directors, effective July 17, 2026.

According to a company statement, Dr. Gaur's resignation was not the result of any disagreement with the company or the board on any matter relating to operations, policies, or practices.

Douglas Hudson resigns from Allurion Technologies board

Tue, 07 Jul 2026 08:09:42 -0400

Douglas Hudson resigned from the board of directors of Allurion Technologies (OTC: ALUR) on June 30, 2026, also vacating his position on the company's Nominating and Corporate Governance Committee.

According to a company statement, Hudson's departure was not related to any disagreement with management or the board on matters concerning the company's operations, policies, or practices.

Hudson served as a Class II member of the board. The board said it is evaluating which of its remaining directors will fill his seat on the Nominating and Corporate Governance Committee.

Douglas Hudson resigns from Allurion Technologies board

Tue, 07 Jul 2026 08:09:42 -0400

Douglas Hudson resigned from the board of directors of Allurion Technologies (OTC: ALUR) on June 30, 2026, also vacating his position on the company's Nominating and Corporate Governance Committee.

According to a company statement, Hudson's departure was not related to any disagreement with management or the board on matters concerning the company's operations, policies, or practices.

Hudson served as a Class II member of the board. The board said it is evaluating which of its remaining directors will fill his seat on the Nominating and Corporate Governance Committee.

Form 8-K ALLURION TECHNOLOGIES, For: Jun 12

Wed, 17 Jun 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260617/26660498.html

Form 8-K ALLURION TECHNOLOGIES, For: Jun 12

Wed, 17 Jun 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260617/26660498.html

Allurion announces 1-for-15 reverse stock split ahead of re-listing

Wed, 17 Jun 2026 16:05:29 -0400

Allurion Technologies, Inc. (OTCQB: ALUR) announced a 1-for-15 reverse stock split of its outstanding common stock, set to take effect at 12:01 a.m. Eastern Time on June 18, 2026, according to a press release from the company.

The move is intended to support regaining compliance with the continued listing requirements of the New York Stock Exchange (NYSE) or the initial listing requirements of the NYSE American.

Under the terms of the reverse stock split, every 15 issued shares of common stock will be combined into one share, with no change to the par value per share. This will reduce outstanding shares from

Allurion announces 1-for-15 reverse stock split ahead of re-listing

Wed, 17 Jun 2026 16:05:29 -0400

The move is intended to support regaining compliance with the continued listing requirements of the New York Stock Exchange (NYSE) or the initial listing requirements of the NYSE American.

Under the terms of the reverse stock split, every 15 issued shares of common stock will be combined into one share, with no change to the par value per share. This will reduce outstanding shares from

Allurion Advances Plan to Re-List

Wed, 17 Jun 2026 16:05:00 -0400

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced a 1-for-15 reverse stock of its outstanding common stock intended to support regaining compliance with the continued listing requirements of the New York Stock Exchange (the “NYSE”) or initial listing requirements of the NYSE American.

Allurion continues to actively engage with national exchanges and is advancing its re-listing strategy as part of a comprehensive plan to strengthen its capital markets positioning.

“We have had a constructive and collaborative dialogue with the national exchanges throughout this process, and we remain focused on meeting

Allurion Advances Plan to Re-List

Wed, 17 Jun 2026 16:05:00 -0400

Allurion continues to actively engage with national exchanges and is advancing its re-listing strategy as part of a comprehensive plan to strengthen its capital markets positioning.

“We have had a constructive and collaborative dialogue with the national exchanges throughout this process, and we remain focused on meeting

Allurion Advances Plan to Re-List

Wed, 17 Jun 2026 16:05:00 -0400

Allurion continues to actively engage with national exchanges and is advancing its re-listing strategy as part of a comprehensive plan to strengthen its capital markets positioning.

“We have had a constructive and collaborative dialogue with the national exchanges throughout this process, and we remain focused on meeting

Allurion Advances Plan to Re-List

Wed, 17 Jun 2026 16:05:00 -0400

Allurion continues to actively engage with national exchanges and is advancing its re-listing strategy as part of a comprehensive plan to strengthen its capital markets positioning.

“We have had a constructive and collaborative dialogue with the national exchanges throughout this process, and we remain focused on meeting

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Tue, 02 Jun 2026 09:00:00 -0400

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (OTCQB: ALUR), a pioneer in metabolically healthy weight loss, today announced successful early traction in the launch of the Allurion Program in the United States, marked by strong clinical outcomes, rapid account growth, high re-order rates, and performance exceeding internal expectations.

First shipments of the Allurion Smart Capsule were completed in April, with the first U.S. patients treated that same month. Early clinical outcomes have been highly encouraging, with patients losing between 8–11% of their total body weight in just the first four weeks, reinforcing the program’s potential to deliver rapid, meaningful

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Tue, 02 Jun 2026 09:00:00 -0400

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Tue, 02 Jun 2026 09:00:00 -0400

Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum

Tue, 02 Jun 2026 09:00:00 -0400

Form 8-K ALLURION TECHNOLOGIES, For: May 20

Wed, 27 May 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260527/26558528.html

Form 8-K ALLURION TECHNOLOGIES, For: May 20

Wed, 27 May 2026 16:36:00 -0400

si-local-file:///var/storage/secattach/20260527/26558528.html

Form 10-Q ALLURION TECHNOLOGIES, For: Mar 31

Fri, 15 May 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26506601.html

Form 10-Q ALLURION TECHNOLOGIES, For: Mar 31

Fri, 15 May 2026 16:35:00 -0400

si-local-file:///var/storage/secattach/20260515/26506601.html